Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term therapy. Found 488 abstracts

no pagination
Lee Z, Jegede OA, Haas NB, Pins MR, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MA, Flaherty KT, Dutcher JP, DiPaola RS, Uzzo RG. Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial. J Urol. 2020 Apr;203(4):684-9.
Margulis V, Puligandla M, Trabulsi EJ, Plimack ER, Kessler ER, Matin SF, Godoy G, Alva A, Hahn NM, Carducci MA, Hoffman-Censits J. Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma. J Urol. 2020 Apr;203(4):690-8.
Wang M, Munoz J, Goy A, Locke FL, Jacobson CA, Hill BT, Timmerman JM, Holmes H, Jaglowski S, Flinn IW, McSweeney PA, Miklos DB, Pagel JM, Kersten MJ, Milpied N, Fung H, Topp MS, Houot R, Beitinjaneh A, Peng W, Zheng L, Rossi JM, Jain RK, Rao AV, Reagan PM. KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma. The New England journal of medicine. 2020 Apr 02;382(14):1331-42.
Chien CR, Geynisman DM, Kim B, Xu Y, Shih YT. Economic Burden of Renal Cell Carcinoma-Part I: An Updated Review. PharmacoEconomics. 2019 Mar;37(3):301-31.   PMCID: PMC6886358
Churilla TM, Chowdhury IH, Handorf E, Collette L, Collette S, Dong Y, Alexander BM, Kocher M, Soffietti R, Claus EB, Weiss SE. Comparison of Local Control of Brain Metastases With Stereotactic Radiosurgery vs Surgical Resection: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol. 2019 Feb;5(2):243-7.   PMCID: PMC6439566
Collins BN, Nair US, Davis SM, Rodriguez D. Increasing Home Smoking Restrictions Boosts Underserved Moms' Bioverified Quit Success. American journal of health behavior. 2019 Jan;43(1):50-6.
Dash PK, Kaminski R, Bella R, Su H, Mathews S, Ahooyi TM, Chen C, Mancuso P, Sariyer R, Ferrante P, Donadoni M, Robinson JA, Sillman B, Lin Z, Hilaire JR, Banoub M, Elango M, Gautam N, Mosley RL, Poluektova LY, McMillan J, Bade AN, Gorantla S, Sariyer IK, Burdo TH, Young WB, Amini S, Gordon J, Jacobson JM, Edagwa B, Khalili K, Gendelman HE. Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice. Nat Commun. 2019 Jul 02;10(1):2753.   PMCID: PMC6606613
Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet (London, England). 2019 Jan 05;393(10166):40-50.   PMCID: PMC6541928
Ji Y, Fioravanti J, Zhu W, Wang H, Wu T, Hu J, Lacey NE, Gautam S, Le Gall JB, Yang X, Hocker JD, Escobar TM, He S, Dell'Orso S, Hawk NV, Kapoor V, Telford WG, Di Croce L, Muljo SA, Zhang Y, Sartorelli V, Gattinoni L. miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8(+) T cell fate. Nat Commun. 2019 May 14;10(1):2157.   PMCID: PMC6517388
Rouvinov K, Plimack ER, Zibelman M, Ghatalia P, Geynisman DM. Update on perioperative systemic therapy for urothelial carcinoma. Clinical advances in hematology & oncology : H&O. 2019 Mar;17(3):176-83.
Alberro JA, Ballester B, Deulofeu P, Fabregas R, Fraile M, Gubern JM, Janer J, Moral A, de Pablo JL, Penalva G, Puig P, Ramos M, Rojo R, Santesteban P, Serra C, Sola M, Solarnau L, Solsona J, Veloso E, Vidal S, Abe O, Abe R, Enomoto K, Kikuchi K, Koyama H, Masuda H, Nomura Y, Ohashi Y, Sakai K, Sugimachi K, Toi M, Tominaga T, Uchino J, Yoshida M, Coles CE, Haybittle JL, Mobus V, Leonard CF, Calais G, Garaud P, Collett V, Davies C, Delmestri A, Sayer J, Harvey VJ, Holdaway IM, Kay RG, Mason BH, Forbe JF, Franci PA, Wilcken N, Balic M, Bartsch R, Fesl C, Fitzal F, Fohler H, Gnant M, Greil R, Jakesz R, Marth C, Mlineritsch B, Pfeiler G, Singer CF, Steger GG, Stoger H, Canney P, Yosef HM, Focan C, Peek U, Oates GD, Powell J, Durand M, Mauriac L, Di Leo A, Dolci S, Larsimont D, Nogaret JM, Philippson C, Piccart MJ, Masood MB, Parker D, Price JJ, Lindsay MA, Mackey J, Martin M, Hupperets P, Bates T, Blamey RW, Chetty U, Ellis IO, Mallon E, Morgan DA, Patnick J, Pinder S, Lohrisch C, Nichol A, Bartlett JM, Bramwell VH, Chen BE, Chia SK, Gelmon K, Goss PE, Levine MN, Parulekar W, Pater JL, Pritchard KI, Shepherd LE, Tu D, Whelan T, Berry D, Broadwater G, Cirrincione C, Muss H, Norton L, Weiss RB, Abu-Zahara HT, Karpov A, Portnoj SL, Bowden S, Brookes C, Dunn J, Fernando I, Lee M, Poole C, Rea D, Spooner D, Barrett-Lee PJ, Manse RE, Monypenny IJ, Gordon NH, Davis HL, Cuzick J, Sestak I, Lehingue Y, Romestaing P, Dubois JB, Delozier T, Griffon B, Lesec'H JM, Mustacchi G, Petruzelka L, Pribylova O, Owen JR, Meier P, Shan Y, Shao YF, Wang X, Zhao DB, Howell A, Swindell R, Albano J, de Oliveira CF, Gervasio H, Gordilho J, Ejlertsen B, Jensen MB, Mouridsen H, Gelman RS, Harris JR, Hayes D, Henderson C, Shapiro CL, Christiansen P, Ejlertsen B, Ewertz M, Jensen MB, Mouridsen HT, Fehm T, Trampisch HJ, Dalesio O, de Vries EG, Rodenhuis S, van Tinteren H, Comis RL, Davidson NE, Gray R, Robert N, Sledge G, Solin LJ, Sparano JA, Tormey DC, Wood W, Cameron D, Chetty U, Dixon JM, Forrest P, Jack W, Kunkler I, Rossbach J, Klijn JG, Treurniet-Donker AD, van Putten WL, Rotmensz N, Veronesi U, Viale G, Bartelink H, Bijker N, Bogaerts J, Cardoso F, Cufer T, Julien JP, Poortmans PM, Rutgers E, van de Velde CJ, Cunningham MP, Huovinen R, Joensuu H, Costa A, Bonadonna G, Gianni L, Valagussa P, Goldstein LJ, Bonneterre J, Fargeot P, Fumoleau P, Kerbrat P, Lupors E, Namer M, Carrasco E, Martin M, Segui MA, Eierman W, Hilfrich J, Jonat W, Kaufmann M, Kreienberg R, Schumacher M, Bastert G, Rauschecker H, Sauer R, Sauerbrei W, Schauer A, Schumacher M, Blohmer JU, Costa SD, Eidtmann H, Gerber B, Jackisch C, Loib S, von Minckwitz G, de Schryver A, Vakaet L, Belfiglio M, Nicolucci A, Pellegrini F, Pirozzoli MC, Sacco M, Valentini M, McArdle CS, Smith DC, Stallard S, Dent DM, Gudgeon CA, Hacking A, Murray E, Panieri E, Werner ID, De Salvo GL, Del Bianco P, Zavagno G, Leone B, Vallejo CT, Zwenger A, Galligioni E, Lopez M, Erazo A, Medina JY, Horiguchi J, Takei H, Fentiman IS, Hayward JL, Rubens RD, Skilton D, Scheurlen H, Kaufmann M, Sohn HC, Untch M, Dafni U, Markopoulos C, Bamia C, Fountzilas G, Koliou GA, Manousou K, Mavroudis D, Klefstrom P, Blomqvist C, Saarto T, Gallen M, Canavese G, Tinterri C, Margreiter R, de Lafontan B, Mihura J, Roche H, Asselain B, Salmon RJ, Vilcoq JR, Brain E, de La Lande B, Mouret-Fourme E, Andre F, Arriagada R, Delaloge S, Hill C, Koscienly S, Michiels S, Rubino C, A'Hern R, Bliss J, Ellis P, Kilburn L, Yarnold JR, Martin M, Benraadt J, Kooi M, van de Velde AO, van Dongen JA, Vermorken JB, Castiglione M, Coates A, Colleoni M, Collins J, Forbes J, Gelbe RD, Goldhirsch A, Lindtner J, Price KN, Regan MM, Rudenstam CM, Senn HJ, Thuerlimann B, Bliss JM, Chilvers CE, Coombes RC, Hall E, Marty M, Buyse M, Possinger K, Schmid P, Untch M, Wallwiener D, Foster L, George WD, Stewart HJ, Stroner P, Borovik R, Hayat H, Inbar MJ, Peretz T, Robinson E, Camerini T, Formelli F, Martelli G, Di Mauro MG, Valagussa P, Perrone F, Amadori D, Martoni A, Pannuti F, Camisa R, Musolino A, Passalacqua R, Iwata H, Shien T, Abe O, Ikeda T, Inokuchi K, Kikuchi K, Sawa K, Sonoo H, Sadoon M, Tulusan AH, Kohno N, Miyashita M, Takao S, Ahn JH, Jung KH, Korzeniowski S, Skolyszewski J, Ogawa M, Yamashita J, Bastiaannet E, Liefers GJ, van de Velde CJ, Christiaens R, Neven P, Paridaens R, Van den Bogaert W, Gazet JC, Corcoran N, Deshpande N, di Martino L, Douglas P, Hacking A, Host H, Lindtner A, Notter G, Bryant AJ, Ewing GH, Firth LA, Krushen-Kosloski JL, Nissen-Meyer R, Anderson H, Killander F, Malmstrom P, Ryden L, Arnesson LG, Carstense J, Dufmats M, Fohlin H, Nordenskjold B, Soderberg M, Sundqvist M, Carpenter TJ, Murray N, Royle GT, Simmonds PD, Albain K, Barlow W, Crowley J, Hayes D, Gralow J, Hortobagyi G, Livingston R, Martino S, Osborne CK, Ravdin PM, Bergh J, Bondesso T, Celebiogl F, Dahlberg K, Fornander T, Fredriksson I, Frisell J, Goransson E, Iiristo M, Johansson U, Lenner E, Lofgren L, Nikolaidis P, Perbeck L, Rotstein S, Sandelin K, Skoog L, Svane G, af Trampe E, Wadstrom C, Janni W, Castiglione M, Goldhirsch A, Maibach R, Senn HJ, Thurlimann B, Bartlett JM, Bastiaannet E, Hadji P, Hozumi J, Rea D, van de Velde CJ, Holli K, Rouhento K, Safra T, Brenner H, Hercbergs A, Yoshimoto M, Paterson AH, Pritchard KI, Fyles A, Meakin JW, Panzarella T, Pritchard KI, Bahi J, Delaloge S, Lemonnier J, Martin AL, Reid M, Spittle M, Bishop H, Bundred NJ, Cuzick J, Ellis IO, Fentiman IS, Forbes JF, Forsyth S, George WS, Pinder SE, Sestak I, Deutsch GP, Gray R, Kwong DL, Pai VR, Peto R, Senanayake F, Boccardo F, Rubagotti A, Baum M, Forsyth S, Hackshaw A, Houghton J, Ledermann J, Monson K, Tobias JS, Carlomagno C, De Laurentiis M, De Placido S, Schem C, Williams L, Bell R, Cameron D, Coleman RE, Dodwell D, Hinsley S, Marshall HC, Hayes D, Pierce LJ, Basso SM, Lumachi F, Solomayer E, Coleman RE, Horsman JM, Lester J, Winter MC, Buzdar AU, Hsu L, Love RR, Ahlgren J, Garmo H, Holmberg L, Lindman H, Warnberg F, Asmar L, Jones SE, Aft R, Gluz O, Harbeck N, Liedtke C, Nitz U, Litton A, Wallgren A, Karlsson P, Linderholm BK, Chlebowski RT, Caffier H, Brufsky AM, Coleman RE, Llombart HA, Ebctcg, Ebctcg, Grocta Trialists. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncology. 2018 Jan;19(1):27-39.
Bass SB, Jessop A, Maurer L, Gashat M, Al Hajji M, Gutierrez M. Mapping the Barriers and Facilitators of HCV Treatment Initiation in Methadone Maintenance Therapy Patients: Implications for Intervention Development. Journal of health communication. 2018 Jan;23(1):117-27.
Chhatre S, Jefferson A, Cook R, Meeker CR, Kim JH, Hartz KM, Wong YN, Caruso A, Newman DK, Morales KH, Jayadevappa R. Patient-centered recruitment and retention for a randomized controlled study. Trials. 2018 Mar 27;19(1):205.   PMCID: PMC5870194
Edwards DC, Cahn DB, Smaldone MC, Kutikov A. Use of administrative data for comparative effectiveness research in the treatment of non-prostate genitourinary malignancies. Urol Oncol. 2018 Apr;36(4):193-212.
Joshi SS, Handorf EA, Zibelman M, Plimack ER, Uzzo RG, Kutikov A, Smaldone MC, Geynisman DM. Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-based Analysis. Eur Urol. 2018 Sep;74(3):387-93.
Kishan AU, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Sandler KA, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Stephenson AJ, Klein EA, Song DY, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco S, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. Jama. 2018 Mar 06;319(9):896-905.   PMCID: PMC5885899
Kluetz PG, Kanapuru B, Lemery S, Johnson LL, Fiero MH, Arscott K, Barbachano Y, Basch E, Campbell M, Cappelleri JC, Cella D, Cleeland C, Coens C, Daniels S, Denlinger CS, Fairclough DL, Hillard JR, Minasian L, Mitchell SA, O'Connor D, Patel S, Rubin EH, Ryden A, Soltys K, Sridhara R, Thanarajasingam G, Velikova G, Coons SJ. Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2018 Jun;21(6):742-7.
Kluetz PG, Kanapuru B, Lemery S, Johnson LL, Fiero MH, Arscott K, Barbachano Y, Basch E, Campbell M, Cappelleri JC, Cella D, Cleeland C, Coens C, Daniels S, Denlinger CS, Fairclough DL, Hillard JR, Minasian L, Mitchell SA, O'Connor D, Patel S, Rubin EH, Ryden A, Soltys K, Sridhara R, Thanarajasingam G, Velikova G, Coons SJ. Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop. Value Health. 2018 Jun;21(6):742-7.
Lyu Z, Kang L, Buuh ZY, Jiang D, McGuth JC, Du J, Wissler HL, Cai W, Wang RE. A Switchable Site-Specific Antibody Conjugate. ACS chemical biology. 2018 Apr 20;13(4):958-64.   PMCID: PMC5910183
Roach M, Moughan J, Lawton CA, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR, Shipley WU, Sandler HM. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. Lancet Oncol. 2018 Nov;19(11):1504-15.   PMCID: PMC6540797
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term therapy

therapy Male Middle Aged methods Treatment Outcome therapeutic use mortality Female Aged Adult adverse effects pathology administration & dosage drug therapy United States Antineoplastic Agents Kidney Neoplasms Time Factors Neoplasm Grading surgery Risk Assessment 80 and over Aged Renal Cell Carcinoma Neoplasms Neoplasm Staging Combined Modality Therapy Prostatic Neoplasms Drug Administration Schedule immunology secondary Medical Oncology Risk Factors Critical Pathways Registries United States Food and Drug Administration Surveys and Questionnaires Disease-Free Survival Randomized Controlled Trials as Topic Follow-Up Studies Urothelium Mice genetics Prospective Studies Chemoradiotherapy Neoadjuvant Therapy Survival Analysis Disease Progression Patient Reported Outcome Measures analogs & derivatives Cisplatin Retrospective Studies virology Comparative Effectiveness Research tolerability Local Neoplasm Recurrence Neoplasm Metastasis oncology carcinoma Drug-Related Side Effects and Adverse Reactions transplantation Antineoplastic Combined Chemotherapy Protocols diagnostic imaging drug safety patient-reported outcomes Pro-ctcae metabolism Adoptive Transfer blood Vulnerable Populations Hepatitis C Flutamide Transitional Cell Carcinoma Switch Genes Mantle-Cell Lymphoma High-Volume Hospitals Preschool Child CD8-Positive T-Lymphocytes Cost of Illness Infant HIV-1 Carcinoma Opiate Substitution Treatment Binding Sites Attitudes Health Knowledge-Practice Adoptive Immunotherapy Health Services Accessibility Canada Prostatectomy Renal cell carcinoma urinary tract Counseling Patient Dropouts Young Adult Datasets as Topic Intensity-Modulated Radiotherapy Anti-HIV Agents Viral DNA drug effects Experimental Melanoma adverse Cancer survival Ureteral Neoplasms Brain Neoplasms survival Neoplastic Gene Expression Regulation local Adenocarcinoma Phase III Clinical Trials as Topic Radiotherapy Polycomb Repressive Complex 2 Urinary Bladder Neoplasms statistics & numerical data Sulfonamides Papillomavirus Infections effects recurrence Perioperative Care Cellular Senescence Minority Groups Prognosis Smoking Prevention T-Lymphocytes Gene Editing Knockout Mice Androgen Antagonists Health Care Outcome and Process Assessment Phenylalanine Peptides Sorafenib radiotherapy urothelium diagnosis Adjuvant Chemotherapy Nephrectomy economics Goserelin physiology Philadelphia Cetuximab Antibodies Neurosurgical Procedures Comparative effectiveness research Health Care Surveys Patient Selection Leukapheresis chemistry methotrexate Neoplasm Invasiveness Terminator Codon Immunoglobulin Fab Fragments
Last updated on Friday, July 10, 2020